Literature DB >> 511334

Infectious episodes in severely granulocytopenic patients.

J W van der Meer, M Alleman, M Boekhout.   

Abstract

In a prospective study, 40 episodes of granulocytopenia (granulocytes less than 500/mm3) in 34 patients were analyzed. During 52.5% of these episodes there was proven infection; these infections were present for only 24.4% of the 1,435 granulocytopenic days. The risk of infection and mortality were closely linked with extreme granulocytopenia (granulocytes less than 100/mm3). Of the episodes with severe granulocytopenia (granulocytes 100-500/mm3) only a small number were associated with infections, and mortality was virtually absent in this category. These results implicated a restricted use of supportive measures (e.g. granulocyte transfusions) especially when granulcotye counts are higher than 100 mm3.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511334     DOI: 10.1007/bf01640936

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia.

Authors:  M H Tattersall; A S Spiers; J H Darrell
Journal:  Lancet       Date:  1972-01-22       Impact factor: 79.321

2.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

Authors:  A S Levine; S E Siegel; A D Schreiber; J Hauser; H Preisler; I M Goldstein; F Seidler; R Simon; S Perry; J E Bennett; E S Henderson
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

3.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

4.  Neutrophils in the blood bank.

Authors:  D R Boggs
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

5.  Prophylactic co-trimoxazole in leukaemia.

Authors:  H F Guiot; J W van der Meer; R van Furth
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

6.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

7.  Removal of leukocytes from whole blood and erythrocyte suspensions by filtration through cotton wool. I. Filtration technique.

Authors:  P Diepenhorst; R Sprokholt; H K Prins
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

8.  Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study.

Authors:  R H Herzig; G P Herzig; R G Graw; M I Bull; K K Ray
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

9.  Partial antibiotic decontamination.

Authors:  H F Guiot; R Furth
Journal:  Br Med J       Date:  1977-03-26

10.  Granulocytopenia in hospitalized patients: I. Prognostic factors and etiology of fever.

Authors:  M J Gurwith; J L Brunton; B A Lank; A R Ronald; G K Harding
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

View more
  3 in total

Review 1.  Modulation of the host flora.

Authors:  R van Furth; H F Guiot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

2.  Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis.

Authors:  M J Meddens; J Thompson; W C Bauer; J Hermans; R van Furth
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

3.  A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.

Authors:  J W van der Meer; M Barza; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.